La ligne téléphonique n’est pas disponible pour le moment.Pour toute demande veuillez envoyer un email a support@advfn.fr

Actualités Merck - MRK

Les meilleurs offres pour accéder les cours en temps réel en illimité
Trader
Abonnement Mensuel
Seulement
34,09 €
Trade Alert US
Abonnement Mensuel
Seulement
52,79 €
Expert
Abonnement Mensuel
Seulement
92,39 €
Prix hors taxes
Nom Action Symbole Action Marché Type ISIN Description Action
Merck MRK NYSE Action ordinaire
  Variation Action Variation Action% Cours Dernier Plus Haut Plus Bas Ouverture Clôture Veille Dernier échange
  0,88 1,04% 85,45 86,03 84,74 84,97 84,57 19:25:30
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
20/6/201921:25EDGARAnnual Report of Employee Stock Plans (11-k)
20/6/201921:23EDGARAnnual Report of Employee Stock Plans (11-k)
20/6/201921:22EDGARAnnual Report of Employee Stock Plans (11-k)
20/6/201912:45BWMerck Hosts 2019 Investor Day Outlining Bus. Momentum,..
20/6/201909:02DJNMerck Seeks Deals As It Expands Its Cancer Treatments -- WSJ
19/6/201912:45BWAstraZeneca & Merck’s LYNPARZA® (olaparib) Approved in Japan..
19/6/201912:37DJFRMerck cherche de nouvelles cibles d'acquisition - sources
19/6/201911:59DJNMerck Seeks More Deals
18/6/201912:45BWFDA Approves Merck’s KEYTRUDA® (pembrolizumab) as..
18/6/201912:30BWLYNPARZA® (olaparib) Approved in the EU for Use as..
17/6/201920:36DJFRBOURSE: La dernière acquisition de Pfizer dope les cours..
15/6/201909:02DJNDrug Firms Sue Over Ad Rule -- WSJ
15/6/201900:27DJNDrugmakers Sue to Block Federal Rule Requiring Drug Prices..
13/6/201914:05PRNUSIBM, KPMG, Merck and Walmart to collaborate as part of FDA's..
11/6/201912:45BWFDA Approves Two New Indications for Merck’s KEYTRUDA®..
10/6/201914:19DJFRMerck va acquérir Tilos Therapeutics pour un montant allant..
10/6/201913:37DJNMerck to Buy Tilos Therapeutics for Up to $773 Million
10/6/201912:45BWMerck to Acquire Tilos Therapeutics
04/6/201923:22EDGARStatement of Changes in Beneficial Ownership (4)
04/6/201923:21EDGARStatement of Changes in Beneficial Ownership (4)
04/6/201923:21EDGARStatement of Changes in Beneficial Ownership (4)
04/6/201923:21EDGARStatement of Changes in Beneficial Ownership (4)
04/6/201923:20EDGARStatement of Changes in Beneficial Ownership (4)
04/6/201923:20EDGARStatement of Changes in Beneficial Ownership (4)
04/6/201923:20EDGARStatement of Changes in Beneficial Ownership (4)
04/6/201923:20EDGARStatement of Changes in Beneficial Ownership (4)
04/6/201923:19EDGARStatement of Changes in Beneficial Ownership (4)
04/6/201923:19EDGARStatement of Changes in Beneficial Ownership (4)
04/6/201923:19EDGARStatement of Changes in Beneficial Ownership (4)
03/6/201922:55BWFDA Approves Merck’s ZERBAXA® (ceftolozane & tazobactam) 3g..
03/6/201922:15BWLYNPARZA® (olaparib) Phase 3 SOLO3 Trial Demonstrated a 72%..
03/6/201908:48DJNAstraZeneca Lynparza Trial Results 'Unprecedented'
02/6/201913:30BWLYNPARZA® (olaparib) First-Line Maintenance Therapy Nearly..
01/6/201913:30BWFive-Year Survival Data for Merck’s KEYTRUDA®..
31/5/201916:56EDGARCurrent Report Filing (8-k)
31/5/201912:45BWMerck’s KEYTRUDA® (pembrolizumab) Demonstrates Improved..
29/5/201920:30DJNJohnson & Johnson Weighs on Pharmaceutical ETFs
28/5/201922:05BWMerck Announces Third-Quarter 2019 Dividend
23/5/201916:44EDGARSpecialized Disclosure Report (sd)
22/5/201914:00BWMerck Foundation Announces Grant to American Cancer Society..
21/5/201915:46DJNMerck to Buy Cancer Drug Maker Peloton Therapeutics -- 2nd..
21/5/201914:23DJNMerck to Buy Cancer Drug Maker Peloton Therapeutics --..
21/5/201914:00DJNMerck to Buy Peloton Therapeutics
21/5/201913:57DJFRMerck rachète Peloton Therapeutics pour un montant pouvant..
21/5/201912:45BWMerck to Acquire Peloton Therapeutics, Bolstering Oncology..
21/5/201900:51DJNCourt Rules Judge, not Jury, Should Rule on Merck Fosamax..
20/5/201923:49DJFRCancer: nouveaux résultats cliniques décevants pour le..
20/5/201923:24DJNMerck Says Keytruda Didn't Meet Primary Endpoint in..
20/5/201922:30BWMerck Provides Update on Phase 3 KEYNOTE-119 Study of..
20/5/201920:20DJNSupreme Court Asks Lower Court to Reconsider Merck Ruling..
Voir d'autres actualités liées à cette action »
Dernières Valeurs Consultées
NYSE
MRK
Merck
Inscrivez-vous aujourd'hui pour consulter ce titre en streaming sur le Moniteur ADVFN. Vous pourrez ajouter et visualiser jusqu'à 110 des vos actions préférée et c'est complètement gratuit..

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Conditions Générales

P: V: D:20190624 17:40:31